156 related articles for article (PubMed ID: 32133571)
1. Delivery of Small Molecule EF2 Kinase Inhibitor for Breast and Pancreatic Cancer Cells Using Hyaluronic Acid Based Nanogels.
Comert Onder F; Sagbas Suner S; Sahiner N; Ay M; Ozpolat B
Pharm Res; 2020 Mar; 37(3):63. PubMed ID: 32133571
[TBL] [Abstract][Full Text] [Related]
2. Hyaluronic acid and hyaluronic acid: Sucrose nanogels for hydrophobic cancer drug delivery.
Sagbas Suner S; Ari B; Onder FC; Ozpolat B; Ay M; Sahiner N
Int J Biol Macromol; 2019 Apr; 126():1150-1157. PubMed ID: 30625351
[TBL] [Abstract][Full Text] [Related]
3. Hyaluronic acid-capped compact silica-supported mesoporous titania nanoparticles for ligand-directed delivery of doxorubicin.
Gupta B; Poudel BK; Ruttala HB; Regmi S; Pathak S; Gautam M; Jin SG; Jeong JH; Choi HG; Ku SK; Yong CS; Kim JO
Acta Biomater; 2018 Oct; 80():364-377. PubMed ID: 30201431
[TBL] [Abstract][Full Text] [Related]
4. Hyaluronan magnetic nanoparticle for mitoxantrone delivery toward CD44-positive cancer cells.
Sargazi A; Shiri F; Keikha S; Majd MH
Colloids Surf B Biointerfaces; 2018 Nov; 171():150-158. PubMed ID: 30025377
[TBL] [Abstract][Full Text] [Related]
5. Design, synthesis and structure-activity relationship of a focused library of β-phenylalanine derivatives as novel eEF2K inhibitors with apoptosis-inducing mechanisms in breast cancer.
Guo Y; Zhao Y; Wang G; Chen Y; Jiang Y; Ouyang L; Liu B
Eur J Med Chem; 2018 Jan; 143():402-418. PubMed ID: 29202403
[TBL] [Abstract][Full Text] [Related]
6. Redox-Sensitive and Intrinsically Fluorescent Photoclick Hyaluronic Acid Nanogels for Traceable and Targeted Delivery of Cytochrome c to Breast Tumor in Mice.
Li S; Zhang J; Deng C; Meng F; Yu L; Zhong Z
ACS Appl Mater Interfaces; 2016 Aug; 8(33):21155-62. PubMed ID: 27509045
[TBL] [Abstract][Full Text] [Related]
7. Folate conjugated hyaluronic acid coated alginate nanogels encapsulated oxaliplatin enhance antitumor and apoptosis efficacy on colorectal cancer cells (HT29 cell line).
Shad PM; Karizi SZ; Javan RS; Mirzaie A; Noorbazargan H; Akbarzadeh I; Rezaie H
Toxicol In Vitro; 2020 Jun; 65():104756. PubMed ID: 31884114
[TBL] [Abstract][Full Text] [Related]
8. Hyaluronan-estradiol nanogels as potential drug carriers to target ER+ breast cancer cell line.
Paoletti L; Zoratto N; Benvenuto M; Nardozi D; Angiolini V; Mancini P; Masuelli L; Bei R; Frajese GV; Matricardi P; Nalli M; Di Meo C
Carbohydr Polym; 2023 Aug; 314():120900. PubMed ID: 37173041
[TBL] [Abstract][Full Text] [Related]
9. Hyaluronic acid hydrophilic surface rehabilitating curcumin nanocrystals for targeted breast cancer treatment with prolonged biodistribution.
Ji P; Wang L; Chen Y; Wang S; Wu Z; Qi X
Biomater Sci; 2020 Jan; 8(1):462-472. PubMed ID: 31750450
[TBL] [Abstract][Full Text] [Related]
10. Hyaluronic acid-coated single-walled carbon nanotubes loaded with doxorubicin for the treatment of breast cancer.
Liu D; Zhang Q; Wang J; Fan L; Zhu W; Cai D
Pharmazie; 2019 Feb; 74(2):83-90. PubMed ID: 30782256
[TBL] [Abstract][Full Text] [Related]
11. Hyaluronic acid-modified liposomal honokiol nanocarrier: Enhance anti-metastasis and antitumor efficacy against breast cancer.
Wang J; Liu D; Guan S; Zhu W; Fan L; Zhang Q; Cai D
Carbohydr Polym; 2020 May; 235():115981. PubMed ID: 32122511
[TBL] [Abstract][Full Text] [Related]
12. Reversibly crosslinked hyaluronic acid nanoparticles for active targeting and intelligent delivery of doxorubicin to drug resistant CD44+ human breast tumor xenografts.
Zhong Y; Zhang J; Cheng R; Deng C; Meng F; Xie F; Zhong Z
J Control Release; 2015 May; 205():144-54. PubMed ID: 25596560
[TBL] [Abstract][Full Text] [Related]
13. Smart nanocarrier based on PEGylated hyaluronic acid for cancer therapy.
Choi KY; Yoon HY; Kim JH; Bae SM; Park RW; Kang YM; Kim IS; Kwon IC; Choi K; Jeong SY; Kim K; Park JH
ACS Nano; 2011 Nov; 5(11):8591-9. PubMed ID: 21967065
[TBL] [Abstract][Full Text] [Related]
14. Hyaluronic acid-coated pH sensitive poly (β-amino ester) nanoparticles for co-delivery of embelin and TRAIL plasmid for triple negative breast cancer treatment.
Xu Y; Liu D; Hu J; Ding P; Chen M
Int J Pharm; 2020 Jan; 573():118637. PubMed ID: 31550511
[TBL] [Abstract][Full Text] [Related]
15. Development and mechanistic insight into enhanced cytotoxic potential of hyaluronic acid conjugated nanoparticles in CD44 overexpressing cancer cells.
Saneja A; Nayak D; Srinivas M; Kumar A; Khare V; Katoch A; Goswami A; Vishwakarma RA; Sawant SD; Gupta PN
Eur J Pharm Sci; 2017 Jan; 97():79-91. PubMed ID: 27989859
[TBL] [Abstract][Full Text] [Related]
16. Saporin-loaded CD44 and EGFR dual-targeted nanogels for potent inhibition of metastatic breast cancer in vivo.
Chen J; He H; Deng C; Yin L; Zhong Z
Int J Pharm; 2019 Apr; 560():57-64. PubMed ID: 30699364
[TBL] [Abstract][Full Text] [Related]
17. Hyaluronic Acid Engineered Nanomicelles Loaded with 3,4-Difluorobenzylidene Curcumin for Targeted Killing of CD44+ Stem-Like Pancreatic Cancer Cells.
Kesharwani P; Banerjee S; Padhye S; Sarkar FH; Iyer AK
Biomacromolecules; 2015 Sep; 16(9):3042-53. PubMed ID: 26302089
[TBL] [Abstract][Full Text] [Related]
18. Delivery of mitochondriotropic doxorubicin derivatives using self-assembling hyaluronic acid nanocarriers in doxorubicin-resistant breast cancer.
Liu HN; Guo NN; Guo WW; Huang-Fu MY; Vakili MR; Chen JJ; Xu WH; Wei QC; Han M; Lavasanifar A; Gao JQ
Acta Pharmacol Sin; 2018 Oct; 39(10):1681-1692. PubMed ID: 29849132
[TBL] [Abstract][Full Text] [Related]
19. pH-Sensitive Coiled-Coil Peptide-Cross-Linked Hyaluronic Acid Nanogels: Synthesis and Targeted Intracellular Protein Delivery to CD44 Positive Cancer Cells.
Ding L; Jiang Y; Zhang J; Klok HA; Zhong Z
Biomacromolecules; 2018 Feb; 19(2):555-562. PubMed ID: 29284258
[TBL] [Abstract][Full Text] [Related]
20. Hyaluronic acid-modified cationic nanoparticles overcome enzyme CYP1B1-mediated breast cancer multidrug resistance.
Zhang J; Song J; Liang X; Yin Y; Zuo T; Chen D; Shen Q
Nanomedicine (Lond); 2019 Feb; 14(4):447-464. PubMed ID: 30694105
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
